Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option
(Erstwhile Reliance Pharma Fund - Direct Plan Growth Plan - Bonus Option)
Fund House: Nippon India Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 01-01-2013 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare TRI |
| TER: 0.92% As on (31-05-2024) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 0.0 |
| Total Assets: 8,569.15 Cr As on 30-06-2025(Source:AMFI) |
| Turn over: 12% | Exit Load: 1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units.Nil, thereafter. |
583.7417
5.92 (1.015%)
18.39%
Benchmark: 15.15%
PERFORMANCE
Returns Type:
of :
Start :
End :
Period:
This Scheme
-
vs
NIFTY Healthcare TRI
-
Gold
-
PPF
-
Returns Type:
of :
Period:
Start :
Period:
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Time Taken To Multiply
2x
4x
5x
10x
FUND
0 Years 0 Months
0 Years 0 Months
0 Years 0 Months
1 Years 6 Months
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months
Investment Objective
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. There is no assurance that the investment objective of the Scheme will be achieved.
Current Asset Allocation (%)
Indicators
| Standard Deviation | 14.81 |
| Sharpe Ratio | 1.32 |
| Alpha | 4.38 |
| Beta | 0.85 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
29.81%
Others
0.57%
Large Cap
48.65%
Mid Cap
20.97%
